Major Shift in Demand For HIV Diagnostics Market – New Study For 2021
Rising number of HIV cases is expected to drive demand for HIV Diagnostics, which is further expected to augment the market growth over the forecast period. For instance, according to the Avert.org, the number of HIV cases increased from 36.7 million to around 36.9 million globally, from the year 2016 and 2017 respectively. Moreover, according to the UNAIDS 2019 report, around 37.9 million of global people suffered from HIV in 2018. Increasing prevalence of HIV/AIDS globally and various government initiatives by countries to spread awareness about HIV in people are expected to drive growth of the HIV diagnostic market. Regions with lower literacy rate, where people are not aware about transmission mode of HIV, changing lifestyle, and unsafe sex are the factors that leads to increasing number of HIV cases. Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/hiv-diagnostics-market-422
Rising number of HIV cases is expected to drive demand for HIV Diagnostics, which is further expected to augment the market growth over the forecast period. For instance, according to the Avert.org, the number of HIV cases increased from 36.7 million to around 36.9 million globally, from the year 2016 and 2017 respectively. Moreover, according to the UNAIDS 2019 report, around 37.9 million of global people suffered from HIV in 2018.
Increasing prevalence of HIV/AIDS globally and various government initiatives by countries to spread awareness about HIV in people are expected to drive growth of the HIV diagnostic market. Regions with lower literacy rate, where people are not aware about transmission mode of HIV, changing lifestyle, and unsafe sex are the factors that leads to increasing number of HIV cases.
Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/hiv-diagnostics-market-422
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Segmentation (Scope)<br />
By Product Type<br />
‣ Instruments<br />
‣ Kits and Reagents<br />
By End User<br />
‣ Hospital & Cl<strong>in</strong>ics<br />
‣ Diagnostic Laboratories<br />
‣ Home Care Sett<strong>in</strong>gs<br />
‣ Others<br />
By Region<br />
‣ North America<br />
‣ Lat<strong>in</strong> America<br />
‣ Europe<br />
‣ Asia Pacific<br />
‣ Middle East<br />
‣ Africa<br />
By Test Type<br />
‣ Instruments<br />
Third Generation (Antibody Test)<br />
• Laboratoy-based<br />
• Po<strong>in</strong>t-of-Care<br />
Fourth Generation (Antibody-Antigen (Ab/Ag) Test)<br />
• Laboratoy-based<br />
• Po<strong>in</strong>t-of-Care<br />
Others<br />
‣ Differentiation & Confirmation Test<br />
‣ Monitor<strong>in</strong>g Test<br />
<br />
<br />
CD4 Tests<br />
Viral Load Tests<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Change language